Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...
The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...
A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...
The global biotech giant is making a big bet on the South Philly campus, and says it’ll be hiring locally to fill the jobs.
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
The China fight is on. Last week, the House of Representatives stepped up to the Herculean task of passing 25 bills targeting ...
Round leads the North American healthcare business across the U.S. and Canada. EMD Serono is just the latest of drugmaker to ...
Originally published on Illumina News Center Karina Katalina Moreno has taken a circuitous route to her American dream. She ...
It is part of a sweeping package of bills aimed at countering China’s influence and power, especially in technology, that Congress largely backed this week. The biotech measure, which cleared the ...
Investor's Business Daily on MSN5d
Merck Scores Two Key Victories With Keytruda In Women's CancersMerck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback